379 related articles for article (PubMed ID: 18248320)
1. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
Kaneda Y
Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320
[TBL] [Abstract][Full Text] [Related]
2. Development of HVJ envelope vector and its application to gene therapy.
Kaneda Y; Yamamoto S; Nakajima T
Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
[TBL] [Abstract][Full Text] [Related]
3. HVJ envelope vector, a versatile delivery system: its development, application, and perspectives.
Zhang Q; Li Y; Shi Y; Zhang Y
Biochem Biophys Res Commun; 2008 Aug; 373(3):345-9. PubMed ID: 18588856
[TBL] [Abstract][Full Text] [Related]
4. Development of a transferrin receptor-targeting HVJ-E vector.
Shimbo T; Kawachi M; Saga K; Fujita H; Yamazaki T; Tamai K; Kaneda Y
Biochem Biophys Res Commun; 2007 Dec; 364(3):423-8. PubMed ID: 17961511
[TBL] [Abstract][Full Text] [Related]
5. HVJ liposomes and HVJ envelope vectors.
Kaneda Y
Cold Spring Harb Protoc; 2011 Oct; 2011(10):1281-9. PubMed ID: 21969614
[TBL] [Abstract][Full Text] [Related]
6. Development of HVJ Envelope Vector and Its Application to Gene Therapy.
Kaneda Y; Yamamoto S; Nakajima T
Adv Genet; 2005; 53PA():307-332. PubMed ID: 16243069
[TBL] [Abstract][Full Text] [Related]
7. Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector.
Mima H; Tomoshige R; Kanamori T; Tabata Y; Yamamoto S; Ito S; Tamai K; Kaneda Y
J Gene Med; 2005 Jul; 7(7):888-97. PubMed ID: 15712245
[TBL] [Abstract][Full Text] [Related]
8. A non-replicating oncolytic vector as a novel therapeutic tool against cancer.
Kaneda Y
BMB Rep; 2010 Dec; 43(12):773-80. PubMed ID: 21189152
[TBL] [Abstract][Full Text] [Related]
9. Virosome: a novel vector to enable multi-modal strategies for cancer therapy.
Kaneda Y
Adv Drug Deliv Rev; 2012 Jun; 64(8):730-8. PubMed ID: 21443915
[TBL] [Abstract][Full Text] [Related]
10. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes.
Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R
J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050
[TBL] [Abstract][Full Text] [Related]
11. Efficient delivery of antibody into living cells using a novel HVJ envelope vector system.
Kondo Y; Fushikida K; Fujieda T; Sakai K; Miyata K; Kato F; Kato M
J Immunol Methods; 2008 Mar; 332(1-2):10-7. PubMed ID: 18221753
[TBL] [Abstract][Full Text] [Related]
12. Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector.
Suvanasuthi S; Tamai K; Kaneda Y
J Gene Med; 2007 Jan; 9(1):55-62. PubMed ID: 17149789
[TBL] [Abstract][Full Text] [Related]
13. Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin.
Ito M; Yamamoto S; Nimura K; Hiraoka K; Tamai K; Kaneda Y
J Gene Med; 2005 Aug; 7(8):1044-52. PubMed ID: 15756713
[TBL] [Abstract][Full Text] [Related]
14. Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter.
Kim YD; Park KG; Morishita R; Kaneda Y; Kim SY; Song DK; Kim HS; Nam CW; Lee HC; Lee KU; Park JY; Kim BW; Kim JG; Lee IK
Gene Ther; 2006 Feb; 13(3):216-24. PubMed ID: 16177820
[TBL] [Abstract][Full Text] [Related]
15. New vector innovation for drug delivery: development of fusigenic non-viral particles.
Kaneda Y
Curr Drug Targets; 2003 Nov; 4(8):599-602. PubMed ID: 14577648
[TBL] [Abstract][Full Text] [Related]
16. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.
Yoshizaki M; Hironaka T; Iwasaki H; Ban H; Tokusumi Y; Iida A; Nagai Y; Hasegawa M; Inoue M
J Gene Med; 2006 Sep; 8(9):1151-9. PubMed ID: 16841365
[TBL] [Abstract][Full Text] [Related]
17. A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy.
Kawano H; Komaba S; Kanamori T; Kaneda Y
BMC Med; 2007 Sep; 5():28. PubMed ID: 17883878
[TBL] [Abstract][Full Text] [Related]
18. Functional modification of Sendai virus by siRNA.
Saga K; Tamai K; Kawachi M; Shimbo T; Fujita H; Yamazaki T; Kaneda Y
J Biotechnol; 2008 Feb; 133(3):386-94. PubMed ID: 18093677
[TBL] [Abstract][Full Text] [Related]
19. Sendai virus for gene therapy and vaccination.
Griesenbach U; Inoue M; Hasegawa M; Alton EW
Curr Opin Mol Ther; 2005 Aug; 7(4):346-52. PubMed ID: 16121700
[TBL] [Abstract][Full Text] [Related]
20. Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1beta mediated by a tumor-specific vector, HVJ cationic liposomes.
Miyata T; Yamamoto S; Sakamoto K; Morishita R; Kaneda Y
Cancer Gene Ther; 2001 Nov; 8(11):852-60. PubMed ID: 11773975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
